PRECLINICAL EVALUATION OF BCL2/BCLXL INHIBITION TO ENHANCE THE EFFICACY OF ANTIBODY-DRUG CONJUGATES (ADCS) FOR THE TREATMENT OF DISTINCT BREAST CANCE
$1,271,249FY2016Department of DefenseDOD
President And Fellows Of Harvard College
President And Fellows Of Harvard College